Repository logo
 

Polyglutamine tracts regulate autophagy

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Rubinsztein, DC 
Ashkenazi, A 
Bento, CF 
Ricketts, T 
Vicinanza, M 

Abstract

Expansions of polyglutamine (polyQ) tracts in different proteins cause 9 neurodegenerative conditions, such as Huntington disease and various ataxias. However, many normal mammalian proteins contain shorter polyQ tracts. As these are frequently conserved in multiple species, it is likely that some of these polyQ tracts have important but unknown biological functions. Here we review our recent study showing that the polyQ domain of the deubiquitinase ATXN3/ataxin-3 enables its interaction with BECN1/beclin 1, a key macroautophagy/autophagy initiator. ATXN3 regulates autophagy by deubiquitinating BECN1 and protecting it from proteasomal degradation. Interestingly, expanded polyQ tracts in other polyglutamine disease proteins compete with the shorter ATXN3 polyQ stretch and interfere with the ATXN3-BECN1 interaction. This competition results in decreased BECN1 levels and impaired starvation-induced autophagy, which phenocopies the loss of autophagic function mediated by ATXN3. Our findings describe a new autophagy-protective mechanism that may be altered in multiple neurodegenerative diseases.

Description

Keywords

Beclin 1, Huntington's disease, ataxin-3, autophagy, polyglutamine, spinocerebellar ataxia, Animals, Ataxin-3, Autophagy, Humans, Models, Biological, Mutant Proteins, Peptides, Polymorphism, Genetic, Trinucleotide Repeat Expansion

Journal Title

Autophagy

Conference Name

Journal ISSN

1554-8627
1554-8635

Volume Title

13

Publisher

Taylor & Francis
Sponsorship
Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (095317/Z/11/Z)
We are grateful to Wellcome Trust (Principal Research Fellowship to DCR.) (095317/Z/11/Z), Wellcome Trust Strategic Grant to Cambridge Institute for Medical Research (100140/Z/12/Z)), National Institute for Health Research Biomedical Research Center at Addenbrooke's Hospital, Addenbrooke's Charitable Trust and Federation of European Biochemical Societies (FEBS Long-Term Fellowship to A.A.) for funding.